Log in
Enquire now
Mediomics

Mediomics

Mediomics is a St. Louis-based company founded in 2001 by Yie-Hwa Chang.

OverviewStructured DataIssuesContributors

Contents

mediomics.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Biomedical engineering
Biomedical engineering
‌
Pharmaceuticals
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Engineering
Engineering
Location
St. Louis
St. Louis
0
B2X
B2B
B2B
CEO
‌
Yie-Hwa Chang
Founder
‌
Yie-Hwa Chang
Number of Employees (Ranges)
1 – 10
Email Address
techsupport@mediomics.com0
orders@mediomics.com0
info@mediomics.com0
Phone Number
+131497130280
Full Address
5445 Highland Park Dr Saint Louis​, MO, 63110-1313 United States0
Investors
Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship
Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship
Founded Date
2001
0
Fax Number
+1-314-997-24220
Latest Funding Round Date
June 2009
Latest Funding Type
‌
Grant (money)
Patents Assigned (Count)
2
Country
United States
United States
0

Other attributes

Company Operating Status
Active
Wikidata ID
Q30283023

Mediomics helps scientists and researchers discover drugs. It is a life sciences company specializing in homogeneous assay kits, high affinity binding reagents, and biosensors for detecting biologically and therapeutically important macromolecules, biomarkers, and pathogens.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Mediomics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.